Literature DB >> 21841246

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.

Lisa Mosconi1, Mony de Leon, John Murray, Lezi E, Jianghua Lu, Elizabeth Javier, Pauline McHugh, Russell H Swerdlow.   

Abstract

Biomarker studies demonstrate inheritance of glucose hypometabolism and increased amyloid-β deposition in adult offspring of mothers, but not fathers, affected by late-onset Alzheimer's disease (LOAD). The underlying genetic mechanisms are unknown. We investigated whether cognitively normal (NL) individuals with a maternal history of LOAD (MH) have reduced platelet mitochondrial cytochrome oxidase activity (COX, electron transport chain complex IV) compared to those with paternal (PH) or negative family history (NH). Thirty-six consecutive NL individuals (age 55 ± 15 y, range 27-71 y, 56% female, CDR = 0, MMSE ≥28, 28% APOE-4 carriers), including 12 NH, 12 PH, and 12 MH, received a blood draw to measure platelet mitochondrial COX activity. Citrate synthase activity (CS) was measured as a reference. Groups were comparable for clinical and neuropsychological measures. We found that after correcting for CS, COX activity was reduced by 29% in MH compared to NH, and by 30% in MH compared to PH (p ≤ 0.006). Results remained significant controlling for age, gender, education, and APOE. No differences were found between PH and NH. COX measures discriminated MH from the other groups with accuracy ≥75%, and relative risk ≥3 (p ≤ 0.005). Among NL with LOAD-parents, only those with MH showed reduced COX activity in platelet mitochondria compared to PH and NH. The association between maternal history of LOAD and systemic COX reductions suggests transmission via mitochondrial DNA, which is exclusively maternally inherited in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841246      PMCID: PMC3291954          DOI: 10.3233/JAD-2011-110866

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  40 in total

1.  Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Authors:  S M Khan; D S Cassarino; N N Abramova; P M Keeney; M K Borland; P A Trimmer; C T Krebs; J C Bennett; J K Parks; R H Swerdlow; W D Parker; J P Bennett
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

Review 2.  Mitochondria in Alzheimer's disease.

Authors:  Russell H Swerdlow; Stephen J Kish
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 3.  Cytochrome oxidase: an endogenous metabolic marker for neuronal activity.

Authors:  M T Wong-Riley
Journal:  Trends Neurosci       Date:  1989-03       Impact factor: 13.837

4.  Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Authors:  Robyn A Honea; Russell H Swerdlow; Eric D Vidoni; Jeffrey M Burns
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

5.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.

Authors:  Francesca Bosetti; Francesca Brizzi; Silvia Barogi; Michelangelo Mancuso; Gabriele Siciliano; Elisabetta A Tendi; Luigi Murri; Stanley I Rapoport; Giancarlo Solaini
Journal:  Neurobiol Aging       Date:  2002 May-Jun       Impact factor: 4.673

7.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Shannon McWeeney; Byung S Park; Maria Manczak; Ramana V Gutala; Dara Partovi; Youngsin Jung; Vincent Yau; Robert Searles; Motomi Mori; Joseph Quinn
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

10.  Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.

Authors:  Sandra M Cardoso; Isabel Santana; Russell H Swerdlow; Catarina R Oliveira
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

View more
  48 in total

1.  Maternal family history is associated with Alzheimer's disease biomarkers.

Authors:  Robyn A Honea; Eric D Vidoni; Russell H Swerdlow; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 3.  Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.

Authors:  Fei Yin; Harsh Sancheti; Zhigang Liu; Enrique Cadenas
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

Review 4.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 5.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

Review 6.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

7.  Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism.

Authors:  Ee Phie Tan; Steven R McGreal; Stefan Graw; Robert Tessman; Scott J Koppel; Pramod Dhakal; Zhen Zhang; Miranda Machacek; Natasha E Zachara; Devin C Koestler; Kenneth R Peterson; John P Thyfault; Russell H Swerdlow; Partha Krishnamurthy; Luciano DiTacchio; Udayan Apte; Chad Slawson
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

8.  A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.

Authors:  Heather M Wilkins; Jonathan D Mahnken; Paul Welch; Rebecca Bothwell; Scott Koppel; Richard L Jackson; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

Review 10.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.